MODULATION EINER ANGIOPOIETIN-3-ÄHNLICHEN EXPRESSION
European patent · EP3087183 · In force
Register entry
- Publication number
- EP3087183
- Application number
- EP14874081
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 24, 2014
- Published
- Nov 2, 2016
- Granted
- Aug 26, 2020
- Protection ends at the latest
- Dec 23, 2034
- Next annual fee due
- Dec 31, 2026
- IPC classes
- C12N 15/113 (2010.01)
- Priority
- US 201361920652 P 24.12.2013
- PCT application
- PCT/US2014/072303 24.12.2014
- PCT publication
- WO2015/100394 02.07.2015
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- Jan 1, 2025
Change
Published in Swissreg on 01.01.2025
- Jan 1, 2024
Change
Published in Swissreg on 01.01.2024
- May 8, 2023
Address changed
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel → VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 08.05.2023
- Jan 1, 2023
Change
Published in Swissreg on 01.01.2023
- Sep 25, 2020
Agent entered
- Representative
- Valipat S.A., c/o BOVARD SA Neuchâtel, Rue des Noyers 11, 2000 Neuchâtel
Published in Swissreg on 25.09.2020
- Aug 26, 2020
Granted
Published in Swissreg on 26.08.2020
Parties
Inventor
FREIER, Susan, M.
Carlsbad, CA 92010, US
GRAHAM, Mark, J.
Carlsbad, CA 92010, US
CROOKE, Rosanne, M.
Carlsbad, CA 92010, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.